Legend Biotech Corp Equity
Legend Biotech Corp (LEGN) had Equity of $1.00 billion as of 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Notes
ifrs-full:Equity · last filed 2026-03-10
- 2025-12-31: Equity $1.00B.
- 2025-09-30: Equity $1.01B.
- 2025-06-30: Equity $1.04B.
- 2025-03-31: Equity $1.02B.
| Period end | Equity | Equity as first filed |
|---|---|---|
| 2025-12-31 | $1.00B 20-F · filed 2026-03-10 | |
| 2025-09-30 | $1.01B 6-K · filed 2025-11-12 | |
| 2025-06-30 | $1.04B 6-K · filed 2025-08-11 | |
| 2025-03-31 | $1.02B 6-K · filed 2025-05-13 | |
| 2024-12-31 | $1.04B 20-F · filed 2026-03-10 | $1.04B 20-F · filed 2025-03-11 |
| 2024-09-30 | $1.12B 6-K · filed 2025-11-12 | |
| 2024-06-30 | $1.16B 6-K · filed 2025-08-11 | |
| 2024-03-31 | $1.16B 6-K · filed 2025-05-13 | |
| 2023-12-31 | $1.25B 20-F · filed 2026-03-10 | $1.25B 20-F · filed 2024-03-19 |
| 2023-09-30 | $1.34B 6-K · filed 2024-11-12 | |
| 2023-06-30 | $1.41B 6-K · filed 2024-08-09 | |
| 2023-03-31 | $653.16M 6-K · filed 2024-05-13 | |
| 2022-12-31 | $744.40M 20-F · filed 2026-03-10 | $744.31M 20-F · filed 2023-03-30 |
| 2022-09-30 | $861.93M 6-K · filed 2023-11-20 | |
| 2022-06-30 | $562.63M 6-K · filed 2023-08-15 | |
| 2021-12-31 | $765.94M 20-F · filed 2025-03-11 | $471.21M 20-F · filed 2022-03-31 |
| 2021-06-30 | $339.92M 6-K · filed 2021-08-23 | |
| 2020-12-31 | $597.77M 20-F · filed 2024-03-19 | $280.25M 20-F · filed 2021-04-02 |
| 2020-06-30 | $401.00M 6-K · filed 2021-08-23 | |
| 2020-01-01 | $151.32M 20-F/A · filed 2023-02-17 | |
| 2019-12-31 | $151.32M 20-F · filed 2023-03-30 | -$122.87M 20-F · filed 2021-04-02 |
| 2018-12-31 | $252.91M 20-F/A · filed 2023-02-17 | $8.65M 20-F · filed 2021-04-02 |
| 2017-12-31 | $12.17M 20-F · filed 2021-04-02 |